Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

🚨 Emergency Pod 🚨 RFK announces peptide reclassification! what does this all mean? will the technology brothers finally be able to source peptides not of the sketchy chinese kind? is this legalization or a different thing? are the technology brothers going too far with peptides? Max Marchione and i...

creatine_cycle's profile picture

atlas

36,873 subscribers

44,226 Aufrufe • vor 4 Monaten •via X (Twitter)

Gesundheit & WellnessNachrichten & PolitikWissenschaft & Technologie
LIVE

Anya Rossi• Live Now

Private livecam show

0 Kommentare

Keine Kommentare verfügbar

Kommentare vom Original-Post werden hier angezeigt

Ähnliche Videos

$HIMS 🚨 THE FDA PEPTIDES VOTE IS DAYS AWAY Peptides insider Jesse Morse, M.D. expects approval We discuss the FDA briefing document recommending *against* the 7 peptides, what the odds of approval are for each of the peptides under review (including BPC-157) and why U.S.-made API could be a major advantage for $HIMS 01:37 - FDA briefing document 03:24 - Getting peptides back in front of the FDA 08:58 - Prescribing peptides back in 2017 12:42 - Peptides safety data 16:08 - BPC-157 deep-dive and odds for approval 22:56 - TB-500 deep-dive 26:15 - Approval odds for the other 5 peptides 31:02 - Peptide efficacy data 34:40 - FDA politics and final decisions 40:30 - Peptides market size 42:48 - Training the doctors 47:20 - Shipping hurdles and gray-market risk 53:25 - Why peptides could reshape healthcare Not financial, legal, or medical advice
1:01:13

$HIMS 🚨 THE FDA PEPTIDES VOTE IS DAYS AWAY Peptides insider Jesse Morse, M.D. expects approval We discuss the FDA briefing document recommending *against* the 7 peptides, what the odds of approval are for each of the peptides under review (including BPC-157) and why U.S.-made API could be a major advantage for $HIMS 01:37 - FDA briefing document 03:24 - Getting peptides back in front of the FDA 08:58 - Prescribing peptides back in 2017 12:42 - Peptides safety data 16:08 - BPC-157 deep-dive and odds for approval 22:56 - TB-500 deep-dive 26:15 - Approval odds for the other 5 peptides 31:02 - Peptide efficacy data 34:40 - FDA politics and final decisions 40:30 - Peptides market size 42:48 - Training the doctors 47:20 - Shipping hurdles and gray-market risk 53:25 - Why peptides could reshape healthcare Not financial, legal, or medical advice

Hims House

185,254 Aufrufe • vor 1 Monat

since Max Marchione and i last spoke a bunch of things have happened in the world of peptides from RFK's reclassification to huberman posting to people discovering that bodybuilders got there first (bodybuilders drive the culture). so max and i caught up once again to cover all of this. also the mics should be working in this and i think the color is properly graded but yeah just let me know in the comments if something is off. i know you guys will. cheers 👍 01:21 - RFK peptide reclassification 03:55 - Why are peptides are popular now 05:00 - Bodybuilders did it first 08:50 - Andrew D. Huberman, Ph.D. on a16z 13:25 - Black market vs grey market vs compounding pharmacy 16:35 - The stages of peptide legalization 19:47 - The genie is out of the bottle 23:40 - TJ Parker⚡️ reaction 26:10 - asparagoid reaction 29:29 - Short term vs long term risk tradeoffs
35:13

since Max Marchione and i last spoke a bunch of things have happened in the world of peptides from RFK's reclassification to huberman posting to people discovering that bodybuilders got there first (bodybuilders drive the culture). so max and i caught up once again to cover all of this. also the mics should be working in this and i think the color is properly graded but yeah just let me know in the comments if something is off. i know you guys will. cheers 👍 01:21 - RFK peptide reclassification 03:55 - Why are peptides are popular now 05:00 - Bodybuilders did it first 08:50 - Andrew D. Huberman, Ph.D. on a16z 13:25 - Black market vs grey market vs compounding pharmacy 16:35 - The stages of peptide legalization 19:47 - The genie is out of the bottle 23:40 - TJ Parker⚡️ reaction 26:10 - asparagoid reaction 29:29 - Short term vs long term risk tradeoffs

atlas

86,767 Aufrufe • vor 5 Monaten

🚨 THE PEPTIDES BULL CASE FOR $HIMS Jonah Lupton - Founder & CIO of FirstWave Capital We discuss how peptides fit into Jonah's thesis for Hims, Jonah's $30K/year peptide regimen, the possibility of Hims x Lilly, retatrutide, and why he thinks Hims could 10x over the next 10 years 02:34 - How Jonah got into peptides 03:39 - Current Hims position 05:04 - Original Hims thesis in the teens 09:12 - FDA peptide timeline & July meeting 15:03 - Peptides are "80% of the thesis" 18:37 - Jonah's personal peptide stack 26:00 - Spending $30K a year on peptides 28:47 - Black market and WhatsApp China 30:25 - Gray market and the COA problem 31:05 - Why Hims wins on legitimacy 32:36 - Best, not first 32:54 - Frustration with Hims transparency 35:28 - Speed vs the Apple approach 37:45 - Surviving the Novo scare 42:46 - Branded vs compounded future 44:41 - Why Lilly matters more than Novo 50:18 - Valuation and the 2035 model 57:04 - Wrap up and other peptide plays Not financial, legal, or medical advice
58:38

🚨 THE PEPTIDES BULL CASE FOR $HIMS Jonah Lupton - Founder & CIO of FirstWave Capital We discuss how peptides fit into Jonah's thesis for Hims, Jonah's $30K/year peptide regimen, the possibility of Hims x Lilly, retatrutide, and why he thinks Hims could 10x over the next 10 years 02:34 - How Jonah got into peptides 03:39 - Current Hims position 05:04 - Original Hims thesis in the teens 09:12 - FDA peptide timeline & July meeting 15:03 - Peptides are "80% of the thesis" 18:37 - Jonah's personal peptide stack 26:00 - Spending $30K a year on peptides 28:47 - Black market and WhatsApp China 30:25 - Gray market and the COA problem 31:05 - Why Hims wins on legitimacy 32:36 - Best, not first 32:54 - Frustration with Hims transparency 35:28 - Speed vs the Apple approach 37:45 - Surviving the Novo scare 42:46 - Branded vs compounded future 44:41 - Why Lilly matters more than Novo 50:18 - Valuation and the 2035 model 57:04 - Wrap up and other peptide plays Not financial, legal, or medical advice

Hims House

124,070 Aufrufe • vor 4 Monaten

🚨 NEEDHAM ANALYST RYAN MACDONALD: PEPTIDES COULD BE A $30+ BILLION MARKET AND $HIMS IS POSITIONED TO WIN A BIG SHARE This is most thorough deep-dive we've done on the business side of peptides: We discuss the latest peptide news, how the FDA / PCAC process actually works, the size of the peptide opportunity, $HIMS' potential share, the Novo partnership, branded vs compounded economics, short interest, competition, valuation, and more. 🔥 01:58 - FDA briefing document breakdown 04:15 - The timeline of peptide approval 09:50 - Category 1 vs 503A Bulks List 11:34 - When will telehealths start to sell peptides? 14:25 - Sizing the peptide market 19:31 - Hims’ peptide share 21:55 - Peptide pricing & margins 24:45 - Peptides likely a 2027 revenue story 29:58 - Hims-Novo deal check-in 32:11 - Branded vs compounded GLP-1s margins 35:27 - Pills vs injectables 40:43 - International 42:04 - Hims' moat 46:22 - 2030 targets and valuation models 50:32 - Shorts, insiders, and catalysts Not financial, medical, or legal advice
1:00:30

🚨 NEEDHAM ANALYST RYAN MACDONALD: PEPTIDES COULD BE A $30+ BILLION MARKET AND $HIMS IS POSITIONED TO WIN A BIG SHARE This is most thorough deep-dive we've done on the business side of peptides: We discuss the latest peptide news, how the FDA / PCAC process actually works, the size of the peptide opportunity, $HIMS' potential share, the Novo partnership, branded vs compounded economics, short interest, competition, valuation, and more. 🔥 01:58 - FDA briefing document breakdown 04:15 - The timeline of peptide approval 09:50 - Category 1 vs 503A Bulks List 11:34 - When will telehealths start to sell peptides? 14:25 - Sizing the peptide market 19:31 - Hims’ peptide share 21:55 - Peptide pricing & margins 24:45 - Peptides likely a 2027 revenue story 29:58 - Hims-Novo deal check-in 32:11 - Branded vs compounded GLP-1s margins 35:27 - Pills vs injectables 40:43 - International 42:04 - Hims' moat 46:22 - 2030 targets and valuation models 50:32 - Shorts, insiders, and catalysts Not financial, medical, or legal advice

Hims House

85,085 Aufrufe • vor 1 Monat

🚨 THE PEPTIDE GOLD RUSH @mansizzzzle - The #1 peptide substacker & founder of Chief Longevity Officer We discuss peptide culture, the supply-chain race, and how $HIMS fits in. One of the most fun + fascinating episodes I've ever done. Thank you Mansi!! 02:09 - Background on Mansi 03:45 - Inside peptide culture 06:30 - NAD+ shots and different form factors 08:20 - Peptide culture across cities 10:54 - Dubai’s longevity gold rush 12:21 - Why peptides feel a little like crypto 16:41 - Mansi’s peptide experiments 19:50 - FDA timeline for peptide reclassification 24:46 - Why supply chain wins 26:11 - The synthesis bottleneck 28:15 - China’s scale advantage 30:29 - Why Hims bought CS Bio 31:39 - State laws 33:57 - Who wins the peptide rush 36:51 - Pricing power, tariffs, and trust 41:53 - Why gray markets persist 45:01 - Peptides with real LTV 47:51 - The Flatiron Health for peptides Not financial, legal, or medical advice
50:11

🚨 THE PEPTIDE GOLD RUSH @mansizzzzle - The #1 peptide substacker & founder of Chief Longevity Officer We discuss peptide culture, the supply-chain race, and how $HIMS fits in. One of the most fun + fascinating episodes I've ever done. Thank you Mansi!! 02:09 - Background on Mansi 03:45 - Inside peptide culture 06:30 - NAD+ shots and different form factors 08:20 - Peptide culture across cities 10:54 - Dubai’s longevity gold rush 12:21 - Why peptides feel a little like crypto 16:41 - Mansi’s peptide experiments 19:50 - FDA timeline for peptide reclassification 24:46 - Why supply chain wins 26:11 - The synthesis bottleneck 28:15 - China’s scale advantage 30:29 - Why Hims bought CS Bio 31:39 - State laws 33:57 - Who wins the peptide rush 36:51 - Pricing power, tariffs, and trust 41:53 - Why gray markets persist 45:01 - Peptides with real LTV 47:51 - The Flatiron Health for peptides Not financial, legal, or medical advice

Hims House

196,571 Aufrufe • vor 3 Monaten

🚨 ARE YOU ACCIDENTALLY SELF-VACCINATING WITH PEPTIDES? — HEALTH INFLUENCERS ARE FREAKING OUT People are asking a disturbing question: Are we accidentally self-vaccinating while using peptides? The claim is that Big Pharma (including Pfizer) is putting COVID and other vaccines into peptides. Who uses peptides? Gym bros, health conscious people, and those who skipped the original shots. So how does Big Pharma reach them? By selling them peptides. Health influencers are pushing peptides hard, while allegedly self-vaccinating and calling it a "new discovery." And yes... many of these peptide companies have ties to vaccine giants and Bill Gates. They couldn’t force the shot… so they made you inject it yourself. Do you believe it and would you still use peptides knowing this?
1:19

🚨 ARE YOU ACCIDENTALLY SELF-VACCINATING WITH PEPTIDES? — HEALTH INFLUENCERS ARE FREAKING OUT People are asking a disturbing question: Are we accidentally self-vaccinating while using peptides? The claim is that Big Pharma (including Pfizer) is putting COVID and other vaccines into peptides. Who uses peptides? Gym bros, health conscious people, and those who skipped the original shots. So how does Big Pharma reach them? By selling them peptides. Health influencers are pushing peptides hard, while allegedly self-vaccinating and calling it a "new discovery." And yes... many of these peptide companies have ties to vaccine giants and Bill Gates. They couldn’t force the shot… so they made you inject it yourself. Do you believe it and would you still use peptides knowing this?

HustleBitch

292,784 Aufrufe • vor 1 Monat

i wouldn't get used to polished MOTS but i figured what better way to announce a Superpower partnership than to bring in some cameras and microphones and have a super serious debate on peptides and looksmaxxing with Max Marchione 00:00 - Intro to Peps (Peptides) 2:25 - Addressing potential allegations 3:55 - Peptide messaging 7:20 - BPC-157 12:05 - BPC-157 Cancer risk? 17:55 - The changing definition of medicine 19:05 - How is the peptide craze different to the steroid/SARM craze? 22:45 - FDA approval 26:00 - Looksmaxxing intro 29:00 - Mewing 30:25 - Bone Smashing and Turkish Leg Lengthening 32:55 - Mouth Taping 34:30 - Looksmaxxing with peptides and looksmaxxing as a trend 39:00 - What the hell is on our table?
41:04

i wouldn't get used to polished MOTS but i figured what better way to announce a Superpower partnership than to bring in some cameras and microphones and have a super serious debate on peptides and looksmaxxing with Max Marchione 00:00 - Intro to Peps (Peptides) 2:25 - Addressing potential allegations 3:55 - Peptide messaging 7:20 - BPC-157 12:05 - BPC-157 Cancer risk? 17:55 - The changing definition of medicine 19:05 - How is the peptide craze different to the steroid/SARM craze? 22:45 - FDA approval 26:00 - Looksmaxxing intro 29:00 - Mewing 30:25 - Bone Smashing and Turkish Leg Lengthening 32:55 - Mouth Taping 34:30 - Looksmaxxing with peptides and looksmaxxing as a trend 39:00 - What the hell is on our table?

atlas

33,345 Aufrufe • vor 6 Monaten

In an interview with TBPN, Dr. Andrew Huberman talks about the peptide that will change everything: $LLY Eli Lilly's Retatrutide. He speculates that it will be illegal for $HIMS and other compounders to sell all forms of peptides. How do you think this impacts compounders? Later he clarifies. "Here is what will (likely) soon happen: All compounded and gray market GLPs (reta. and priors) will be highly illegal to sell… meaning any sites carrying these will be uniformly shut down. Other peptides will remain available. This is just a prediction but I’ll take any bet."
4:08

In an interview with TBPN, Dr. Andrew Huberman talks about the peptide that will change everything: $LLY Eli Lilly's Retatrutide. He speculates that it will be illegal for $HIMS and other compounders to sell all forms of peptides. How do you think this impacts compounders? Later he clarifies. "Here is what will (likely) soon happen: All compounded and gray market GLPs (reta. and priors) will be highly illegal to sell… meaning any sites carrying these will be uniformly shut down. Other peptides will remain available. This is just a prediction but I’ll take any bet."

Nikolias Goninus

16,830 Aufrufe • vor 6 Monaten

How Peptides Are Made I was already anti-peptides, but what I discovered as to the specifics of how they are made shocked me. If you are injecting this kind of stuff into your body, you are playing with fire. I personally would never, ever recommend any of these things to put inside your system. Foreign factories, plastics and petrochemicals, as well as forever chemicals and other unknown contaminants, delivered straight into your bloodstream. The natural, holistic path to achieve your goals will always be better, even if it takes longer. Many people that are taking peptides as an easy way out have not gone to the depths of changing their lifestyle to a natural and holistic one that could support improvement in their health. Just say no to peptides! #peptides
1:32

How Peptides Are Made I was already anti-peptides, but what I discovered as to the specifics of how they are made shocked me. If you are injecting this kind of stuff into your body, you are playing with fire. I personally would never, ever recommend any of these things to put inside your system. Foreign factories, plastics and petrochemicals, as well as forever chemicals and other unknown contaminants, delivered straight into your bloodstream. The natural, holistic path to achieve your goals will always be better, even if it takes longer. Many people that are taking peptides as an easy way out have not gone to the depths of changing their lifestyle to a natural and holistic one that could support improvement in their health. Just say no to peptides! #peptides

⚡️🌞 Sol Brah 🌞🐬

44,577 Aufrufe • vor 1 Monat

today, we're announcing our most long-awaited offering – Superpower Peptides. 1 in 5 Americans have already tried a GLP1, but the wave is only beginning. for too long, people seeking access to new peptides have been left with two options: go without, or turn to unregulated sources that put their health at risk. that's beginning to change. and we've been building. introducing Superpower Peptides: • Pure. Third-party tested. • Rigorously sourced • Backed by science as the FDA moves to restore regulated access to 12 key peptides (like BPC 157), we are ready. existing members get early access today. peptides will be one of the biggest revolutions in human health and one of the fastest growing consumer markets next to AI. you can reserve your username on our waitlist here: 👉 superpower . com / peptides __ peptides, by Superpower. a new era of health is coming.
0:25

today, we're announcing our most long-awaited offering – Superpower Peptides. 1 in 5 Americans have already tried a GLP1, but the wave is only beginning. for too long, people seeking access to new peptides have been left with two options: go without, or turn to unregulated sources that put their health at risk. that's beginning to change. and we've been building. introducing Superpower Peptides: • Pure. Third-party tested. • Rigorously sourced • Backed by science as the FDA moves to restore regulated access to 12 key peptides (like BPC 157), we are ready. existing members get early access today. peptides will be one of the biggest revolutions in human health and one of the fastest growing consumer markets next to AI. you can reserve your username on our waitlist here: 👉 superpower . com / peptides __ peptides, by Superpower. a new era of health is coming.

jacob peters

11,001 Aufrufe • vor 4 Monaten

$HIMS $ENHA 🚨 MAX MARTIN & Christian Angermayer SAY ENHANCED WILL BE 'READY TO GO' AS SOON AS THE FDA MOVES PEPTIDES TO CATEGORY 1 "The goal is to be ready immediately after, yes." "Because think about it like this: What actually happens is that when 503A pharmacies are again able to compound those peptides, those are the pharmacies that we are already working with, that we already have the delivery and operational chain set up." "The doctors that are going to be able to prescribe those [peptides] are going to be the same doctors we are already working with." "And so from an infrastructure perspective, not much changes." "So from an infrastructure perspective, we are ready to go as soon as that change happens."
0:52

$HIMS $ENHA 🚨 MAX MARTIN & Christian Angermayer SAY ENHANCED WILL BE 'READY TO GO' AS SOON AS THE FDA MOVES PEPTIDES TO CATEGORY 1 "The goal is to be ready immediately after, yes." "Because think about it like this: What actually happens is that when 503A pharmacies are again able to compound those peptides, those are the pharmacies that we are already working with, that we already have the delivery and operational chain set up." "The doctors that are going to be able to prescribe those [peptides] are going to be the same doctors we are already working with." "And so from an infrastructure perspective, not much changes." "So from an infrastructure perspective, we are ready to go as soon as that change happens."

Hims House

28,393 Aufrufe • vor 3 Monaten

Sexual Wellness Peptides How do you use them? This section/module includes: PT-141 Melanotan I & II Kisspeptin HCG Gonadorelin Oxytocin Testosterone (TRT) Enclomiphene Learning the Peptides isn’t enough. You have to know exactly which pathway in the body they work, and which ones are used in which situations. Which labs need to be monitored, and what is a traditional protocol. Which ones can be stacked? Contraindications? That’s why, during our Peptide certification course, we decided to apply these different peptides, protocols, stacks, and labs to ‘mock’ patients. Watch the example below. Clip taken from Stack Peptide Certification Course. If you’re interested in taking the course, click the link below to join the waitlist. It will be available very soon.
6:16

Sexual Wellness Peptides How do you use them? This section/module includes: PT-141 Melanotan I & II Kisspeptin HCG Gonadorelin Oxytocin Testosterone (TRT) Enclomiphene Learning the Peptides isn’t enough. You have to know exactly which pathway in the body they work, and which ones are used in which situations. Which labs need to be monitored, and what is a traditional protocol. Which ones can be stacked? Contraindications? That’s why, during our Peptide certification course, we decided to apply these different peptides, protocols, stacks, and labs to ‘mock’ patients. Watch the example below. Clip taken from Stack Peptide Certification Course. If you’re interested in taking the course, click the link below to join the waitlist. It will be available very soon.

Jesse Morse, M.D.

34,307 Aufrufe • vor 2 Monaten

well seeing as i missed Chairman Birb Bernanke's peptide soiree in NYC i figured i would at least follow it up with a niche podcast version with Max Marchione we covered: - retatrutide - elli lilly - enhanced games 00:00 - Me rambling by myself in my room 02:58 - Max Marchione intro 04:44 - retatrutide phase 3 trial 06:00 - Crémieux reaction 10:20 - Elli Lilly $1T in market cap 11:17 - MTS reaction 13:56 - Elli Lilly BPC-157? 15:40 - Enhanced Games recap (my words) 20:18 - Max’s thoughts on the Enhanced Games 24:11 - Is it too early to be selling peptides online? 27:15 - Superpower peptide update 29:35 - Peptide sales and reclassification predictions 30:50 - We’re still early
33:48

well seeing as i missed Chairman Birb Bernanke's peptide soiree in NYC i figured i would at least follow it up with a niche podcast version with Max Marchione we covered: - retatrutide - elli lilly - enhanced games 00:00 - Me rambling by myself in my room 02:58 - Max Marchione intro 04:44 - retatrutide phase 3 trial 06:00 - Crémieux reaction 10:20 - Elli Lilly $1T in market cap 11:17 - MTS reaction 13:56 - Elli Lilly BPC-157? 15:40 - Enhanced Games recap (my words) 20:18 - Max’s thoughts on the Enhanced Games 24:11 - Is it too early to be selling peptides online? 27:15 - Superpower peptide update 29:35 - Peptide sales and reclassification predictions 30:50 - We’re still early

atlas

37,704 Aufrufe • vor 2 Monaten

Okay this is disturbing. You know all those Chinese companies that were sending the fentanyl precursors to Mexico to poison our children? Those same companies have now pivoted and are sending peptides into the American market. Many of these are not FDA approved! I think we need to put the brakes on this and get track of who's doing what to whom. Peptides are the wild west right now. Folks are taking a lot of things that they don't really know what's in them. What's your take on this?
1:05

Okay this is disturbing. You know all those Chinese companies that were sending the fentanyl precursors to Mexico to poison our children? Those same companies have now pivoted and are sending peptides into the American market. Many of these are not FDA approved! I think we need to put the brakes on this and get track of who's doing what to whom. Peptides are the wild west right now. Folks are taking a lot of things that they don't really know what's in them. What's your take on this?

Bill Mitchell

12,574 Aufrufe • vor 28 Tagen

BPC-157 causing cancer? FDA shutting down peptide trials? “No human RCTs have ever been done on peptides?” In this video, Dr. Alex Tatem — board-certified urologist and fellowship-trained men’s health specialist — reacts to viral claims made on Shawn Ryan Show about BPC-157, TB-500, peptides, angiogenesis, cancer risk, and peptide safety. We break down: • Whether BPC-157 actually causes cancer • The truth about angiogenesis and tumor growth • FDA regulation of peptides and compounding • Why the “no randomized controlled trials” claim is completely false • Human clinical trial data on peptides • The real history of BPC-157 clinical studies • Huberman’s correction of viral peptide misinformation • Why peptide fearmongering could push patients toward unsafe gray-market sourcing This is not bro-science or influencer hype. This is a deep dive into the actual published literature, peptide pharmacology, FDA policy, and performance medicine. Topics covered include: BPC-157, TB-500, peptides, angiogenesis, cancer biology, GLP-1 drugs, Ozempic, tirzepatide, semaglutide, TRT, peptide therapy, biohacking, longevity, anti-aging medicine, compounding pharmacies, peptide legality, Andrew D. Huberman, Ph.D. , Shawn Ryan Show, FDA peptide regulation, growth hormone history, and performance medicine. If you’ve ever wondered whether BPC-157 is dangerous, whether peptides are legal, or whether the internet is fearmongering about peptide therapy — this video is for you.
20:43

BPC-157 causing cancer? FDA shutting down peptide trials? “No human RCTs have ever been done on peptides?” In this video, Dr. Alex Tatem — board-certified urologist and fellowship-trained men’s health specialist — reacts to viral claims made on Shawn Ryan Show about BPC-157, TB-500, peptides, angiogenesis, cancer risk, and peptide safety. We break down: • Whether BPC-157 actually causes cancer • The truth about angiogenesis and tumor growth • FDA regulation of peptides and compounding • Why the “no randomized controlled trials” claim is completely false • Human clinical trial data on peptides • The real history of BPC-157 clinical studies • Huberman’s correction of viral peptide misinformation • Why peptide fearmongering could push patients toward unsafe gray-market sourcing This is not bro-science or influencer hype. This is a deep dive into the actual published literature, peptide pharmacology, FDA policy, and performance medicine. Topics covered include: BPC-157, TB-500, peptides, angiogenesis, cancer biology, GLP-1 drugs, Ozempic, tirzepatide, semaglutide, TRT, peptide therapy, biohacking, longevity, anti-aging medicine, compounding pharmacies, peptide legality, Andrew D. Huberman, Ph.D. , Shawn Ryan Show, FDA peptide regulation, growth hormone history, and performance medicine. If you’ve ever wondered whether BPC-157 is dangerous, whether peptides are legal, or whether the internet is fearmongering about peptide therapy — this video is for you.

Dr. Alex Tatem

77,230 Aufrufe • vor 3 Monaten

$HIMS THE CAT IS OUT OF THE BAG WITH PEPTIDES Jonathan: "There is no going back to 2010. These have taken over the cultural consciousness and are here to stay... What happens, though, if the 7 peptides are not approved?" Jesse Morse, M.D.: "So here's the problem. The demand is there. Right now, the supply is the problem, and part of that supply is purity and safety." "Millions of people are taking peptides every day in the United States." "Less than 5% of them, if I were to guess, are being compounded by American pharmacies." "That means 95% of the peptides that are not GLPs are being ordered from some random website or picked up at a bodega in New York." "The FDA has to see this, and they have to say, 'Hey, I understand this is not ideal, and we don't have 10 years of beautiful data. But unfortunately, this is the situation we're in.' "
1:32

$HIMS THE CAT IS OUT OF THE BAG WITH PEPTIDES Jonathan: "There is no going back to 2010. These have taken over the cultural consciousness and are here to stay... What happens, though, if the 7 peptides are not approved?" Jesse Morse, M.D.: "So here's the problem. The demand is there. Right now, the supply is the problem, and part of that supply is purity and safety." "Millions of people are taking peptides every day in the United States." "Less than 5% of them, if I were to guess, are being compounded by American pharmacies." "That means 95% of the peptides that are not GLPs are being ordered from some random website or picked up at a bodega in New York." "The FDA has to see this, and they have to say, 'Hey, I understand this is not ideal, and we don't have 10 years of beautiful data. But unfortunately, this is the situation we're in.' "

Hims House

28,542 Aufrufe • vor 1 Monat

Superpower co-founder Max Marchione describes how he went from being a peptide skeptic to a peptide believer: "When I was first introduced to peptides, one of the most esteemed doctors in the US said to me: 'You take so many supplements. Have you explored peptides? Because I think they're a really interesting modality with a few decades of clinical use.'" "When he said that to me, I was like, 'No way. This is BS. I'm not injecting myself with something. That's weird.'" "So what I did is, I went around to around 20 different doctors whose opinions I respect, and I asked them about peptides. Normally when you ask these doctors about anything — you ask about red meat, spinach, [etc.] — they're all divided." "With peptides, all of them except one said 'These are really interesting. I have used these in my patients. I believe endogenous molecules — peptides that exist in our body — are going to be the future of medicine.'" "And those doctors have the incentive not to be wrong. If they're wrong, they could go to jail. If they're wrong, they can have their license stripped. If they're wrong, patients don't come back to them. They have the maximum incentive. And for 10 to 20 years, they still give [peptides] to their patients. And their patients say 'My life changed.'" "You might say it's placebo. My statement is that the patient says their life changes, and the doctor sees that."
1:21

Superpower co-founder Max Marchione describes how he went from being a peptide skeptic to a peptide believer: "When I was first introduced to peptides, one of the most esteemed doctors in the US said to me: 'You take so many supplements. Have you explored peptides? Because I think they're a really interesting modality with a few decades of clinical use.'" "When he said that to me, I was like, 'No way. This is BS. I'm not injecting myself with something. That's weird.'" "So what I did is, I went around to around 20 different doctors whose opinions I respect, and I asked them about peptides. Normally when you ask these doctors about anything — you ask about red meat, spinach, [etc.] — they're all divided." "With peptides, all of them except one said 'These are really interesting. I have used these in my patients. I believe endogenous molecules — peptides that exist in our body — are going to be the future of medicine.'" "And those doctors have the incentive not to be wrong. If they're wrong, they could go to jail. If they're wrong, they can have their license stripped. If they're wrong, patients don't come back to them. They have the maximum incentive. And for 10 to 20 years, they still give [peptides] to their patients. And their patients say 'My life changed.'" "You might say it's placebo. My statement is that the patient says their life changes, and the doctor sees that."

TBPN

37,426 Aufrufe • vor 5 Monaten

BPC-157 and TB-500 are two of the most talked-about peptides in fitness, bodybuilding, and biohacking. Together they’re often called the “Wolverine Stack” — a peptide combination rumored to dramatically accelerate healing of tendons, ligaments, muscles, and injuries. But do BPC-157 and TB-500 actually work in humans, or is the Wolverine Stack just another example of internet bro-science? In this evidence-based deep dive, Dr. Alex Tatem (board-certified urologist and men’s health specialist) breaks down the real science behind BPC-157 and TB-500 — including their biochemical mechanisms, animal research, potential healing effects, safety concerns, and why pharmaceutical companies have never brought these peptides through full FDA clinical trials. We explore the nitric oxide signaling, angiogenesis, VEGF pathways, actin regulation, and tissue repair biology behind these compounds and explain why rodent studies look promising — but why human clinical evidence is still extremely limited. You’ll also learn about: • What BPC-157 (Body Protection Compound-157) actually is • TB-500 vs Thymosin Beta-4 explained • The origin of the Wolverine Stack peptide protocol • Peptides for tendon healing and ligament injuries • BPC-157 for gut healing and musculoskeletal repair • TB-500 and actin-mediated tissue regeneration • Why most peptide research comes from one Croatian research group • The patent law problem preventing pharmaceutical development • Real risks of grey-market peptide contamination • Why WADA bans BPC-157 and TB-500 in competitive athletes • Theoretical cancer risks related to angiogenesis • What the current scientific literature actually shows If you've ever searched: “Does BPC-157 work?” “What is TB-500?” “Peptides for healing injuries” “BPC-157 tendon repair” “Wolverine Stack peptides explained” — this video breaks down the science. The peptides may be promising. But promise and proof are not the same thing. Drop a comment below: Have you ever used BPC-157, TB-500, or other peptides? What was your experience? 👍 Like the video if you want more evidence-based breakdowns of supplements, PEDs, and peptides. Subscribe for deep dives on testosterone, steroids, peptides, supplements, and men’s health science.
30:26

BPC-157 and TB-500 are two of the most talked-about peptides in fitness, bodybuilding, and biohacking. Together they’re often called the “Wolverine Stack” — a peptide combination rumored to dramatically accelerate healing of tendons, ligaments, muscles, and injuries. But do BPC-157 and TB-500 actually work in humans, or is the Wolverine Stack just another example of internet bro-science? In this evidence-based deep dive, Dr. Alex Tatem (board-certified urologist and men’s health specialist) breaks down the real science behind BPC-157 and TB-500 — including their biochemical mechanisms, animal research, potential healing effects, safety concerns, and why pharmaceutical companies have never brought these peptides through full FDA clinical trials. We explore the nitric oxide signaling, angiogenesis, VEGF pathways, actin regulation, and tissue repair biology behind these compounds and explain why rodent studies look promising — but why human clinical evidence is still extremely limited. You’ll also learn about: • What BPC-157 (Body Protection Compound-157) actually is • TB-500 vs Thymosin Beta-4 explained • The origin of the Wolverine Stack peptide protocol • Peptides for tendon healing and ligament injuries • BPC-157 for gut healing and musculoskeletal repair • TB-500 and actin-mediated tissue regeneration • Why most peptide research comes from one Croatian research group • The patent law problem preventing pharmaceutical development • Real risks of grey-market peptide contamination • Why WADA bans BPC-157 and TB-500 in competitive athletes • Theoretical cancer risks related to angiogenesis • What the current scientific literature actually shows If you've ever searched: “Does BPC-157 work?” “What is TB-500?” “Peptides for healing injuries” “BPC-157 tendon repair” “Wolverine Stack peptides explained” — this video breaks down the science. The peptides may be promising. But promise and proof are not the same thing. Drop a comment below: Have you ever used BPC-157, TB-500, or other peptides? What was your experience? 👍 Like the video if you want more evidence-based breakdowns of supplements, PEDs, and peptides. Subscribe for deep dives on testosterone, steroids, peptides, supplements, and men’s health science.

Dr. Alex Tatem

22,510 Aufrufe • vor 5 Monaten

$HIMS $LLY $NVO 🚨 BREAKING: Noom is acquiring a 503A pharmacy to prepare for the peptide boom We sat down with Geoff Cook (Noom CEO) to discuss why vertical integration is so important, how large the peptide market is going to be, and the evolving dynamics between telehealth platforms and big pharma A great episode with one of the best CEOs in the game - thanks again, Geoff! 00:00 - Why pharma needs DTC platforms 03:03 - Noom's 90% revenue growth 05:01 - Why Noom bought Tailor Made Compounding 07:29 - The case for vertical integration 08:56 - Compounded GLP-1s aren't going anywhere 16:48 - The Hims-Novo deal 19:08 - Noom's pitch to next-gen pharma 24:24 - Peptide market sizing 25:33 - Why GLP-1 users will buy peptides first 27:22 - Ten million potential peptide patients 👀 30:09 - When will legalization happen? 31:09 - Tracking the FDA green list 34:26 - Who wins when peptides go legal? 37:58 - Why Noom won't rush peptide launch 39:33 - Geoff's BPC-157 ski injury recovery 46:42 - Expanding at-home labs past 30 biomarkers 52:47 - Noom IPO coming?! Not financial, legal, or medical advice
53:50

$HIMS $LLY $NVO 🚨 BREAKING: Noom is acquiring a 503A pharmacy to prepare for the peptide boom We sat down with Geoff Cook (Noom CEO) to discuss why vertical integration is so important, how large the peptide market is going to be, and the evolving dynamics between telehealth platforms and big pharma A great episode with one of the best CEOs in the game - thanks again, Geoff! 00:00 - Why pharma needs DTC platforms 03:03 - Noom's 90% revenue growth 05:01 - Why Noom bought Tailor Made Compounding 07:29 - The case for vertical integration 08:56 - Compounded GLP-1s aren't going anywhere 16:48 - The Hims-Novo deal 19:08 - Noom's pitch to next-gen pharma 24:24 - Peptide market sizing 25:33 - Why GLP-1 users will buy peptides first 27:22 - Ten million potential peptide patients 👀 30:09 - When will legalization happen? 31:09 - Tracking the FDA green list 34:26 - Who wins when peptides go legal? 37:58 - Why Noom won't rush peptide launch 39:33 - Geoff's BPC-157 ski injury recovery 46:42 - Expanding at-home labs past 30 biomarkers 52:47 - Noom IPO coming?! Not financial, legal, or medical advice

Hims House

55,711 Aufrufe • vor 4 Monaten